Back

Effects of omega-3 fatty acids on dementia and cognitive Impairment in the ASCEND trial

26 August 2022 (16:15 - 17:00)
Organised by:
Congress Presentation Part of: Nutrition, malnutrition and heart disease Nutrition, Malnutrition and Heart Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Marion Mafham

Clinical Trial Service Unit University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Serum magnesium is associated with long-term survival of non-ST-elevation myocardial infarction patients
Professor M. Shechter (Ramat Gan, IL)
Abstract Slides
Presentation thumbnail
Associations of dietary macronutrient composition with cardiometabolic health: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2014
Mr N. Koemel (Camperdown, AU)
Abstract Slides
Presentation thumbnail
Selenium concentration and cardiovascular disease risk: Mendelian randomization study
Doctor S. Yuan (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Effects of omega-3 fatty acid supplementation on the risk of atrial fibrillation (AF) and micro-AF in the OMEMI trial
Doctor P. Myhre (Oslo, NO)
Abstract Slides
Presentation thumbnail
Trimethylamine N-oxide is associated with impaired cognitive function in patients with atrial fibrillation
Ms T. Ziswiler (Baden, CH)
Abstract Slides

Access the full session

Session thumbnail
Nutrition, malnutrition and heart disease

The Event

Event poster

ESC Congress 2022

26 August 2022 16:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources